Bris­tol My­ers to lay off over 500 work­ers in New Jer­sey

3 weeks ago
People
Pharma

Even as ques­tions grow over RFK Jr.'s vac­cine pol­i­cy, BioN­Tech does­n't see ‘near-term’ im­pact

3 weeks ago
R&D
Pharma

Func­tion buys Ezra, cre­at­ing one-stop shop for pre­ven­tive test­ing and scans

3 weeks ago
Startups
Deals

Re­cur­sion cuts near­ly half of its pipeline, in­clud­ing its most ad­vanced pro­gram

3 weeks ago
R&D
AI

Uni­ty lays off 'al­l' work­ers; No­vo to get FDA de­ci­sion on oral We­govy this year

3 weeks ago
News Briefing

J&J's eye dis­ease gene ther­a­py bo­ta-vec fails in Phase 3 tri­al

3 weeks ago
R&D
Cell/Gene Tx

Iambic de­buts next ver­sion of AI mod­el En­chant, dri­ving new way for drug R&D

3 weeks ago
AI

Ex­clu­sive: Deer­field se­cures $600M+ for third health­care ven­ture fund to seed new com­pa­nies

3 weeks ago
Financing
Startups

Post-Hoc: The big ques­tion for the FDA af­ter Stealth’s PDU­FA de­lay

3 weeks ago
FDA+

Ear­ly bits of in vi­vo CAR-T hu­man da­ta emerge from biotech tri­als in Chi­na

3 weeks ago
R&D
China

Ex­clu­sive: Topas claims suc­cess in ear­ly test of 'im­mune tol­er­ance' ther­a­py for celi­ac dis­ease

3 weeks ago
R&D

Earn­ings sea­son con­tin­ues; FDA de­lays PDU­FA date; AACR re­cap; and more

4 weeks ago
Weekly

Ex­clu­sive: Ver­tex drops AAV gene ther­a­py re­search, tR­NA ther­a­py part­ner­ship

4 weeks ago
R&D
Cell/Gene Tx

Ex­clu­sive: Af­ter FDA fir­ings, drug re­view­ers are asked to vol­un­teer for ad­min­is­tra­tive work

4 weeks ago
FDA+

White House bud­get re­quest would cut bil­lions at NIH and CDC, add $500M for MA­HA

4 weeks ago
Pharma
FDA+

FDA with­draws two fi­nal guid­ances, pulls com­pli­ance dead­lines for bone al­lo­graft mak­ers

4 weeks ago
R&D
Pharma

Feng Zhang’s pro­tein nanopar­ti­cle start­up Aera Ther­a­peu­tics turns to lipid nanopar­ti­cles to jump­start its pipeline

4 weeks ago
R&D
Cell/Gene Tx

Drug­mak­ers ex­ploit can­cer’s ‘lethal­i­ties’ to make next class of tar­get­ed ther­a­pies, with first re­sults for ...

4 weeks ago
R&D

Pathos AI gets As­traZeneca fund­ing as biotech plans to raise up to $400M

4 weeks ago
Financing
Startups

Ku­ra gets $45M mile­stone pay­ment from Ky­owa Kirin; Pli­ant’s re­struc­tur­ing

4 weeks ago
News Briefing

The in­side sto­ry of how Sali­o­Gen, a start­up try­ing to wran­gle ‘jump­ing genes’ to make med­i­cines, fell apart

4 weeks ago
Startups
In Focus

For­mer Tome CEO joins Flag­ship start­up; NGM Bio chief steps down as re­struc­tur­ing takes ef­fect

4 weeks ago
Peer Review

In­vestors un­veil plans for $1.3B can­cer hub in Lon­don sub­urbs

4 weeks ago
R&D
Manufacturing

Miss­ing REMS de­lays Cy­to­ki­net­ic­s' heart drug PDU­FA, stock drops

4 weeks ago
Pharma
FDA+
First page Previous page 6789101112 Next page Last page
A service from the Financial Times